Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · IEX Real-Time Price · USD
120.42
-0.09 (-0.07%)
At close: Mar 28, 2024, 4:00 PM
118.25
-2.17 (-1.80%)
After-hours: Mar 28, 2024, 7:35 PM EDT

Jazz Pharmaceuticals Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2004
Revenue
3,8343,6593,0942,3642,1621,8911,6191,4881,3251,173
Upgrade
Revenue Growth (YoY)
4.78%18.26%30.91%9.34%14.32%16.82%8.79%12.32%12.95%34.44%
Upgrade
Cost of Revenue
435.58540.52440.76148.92127.93121.54110.19105.39102.53117.42
Upgrade
Gross Profit
3,3993,1192,6532,2152,0341,7691,5091,3831,2221,055
Upgrade
Selling, General & Admin
1,3431,4171,452854.23736.94683.53544.16502.89449.12406.11
Upgrade
Research & Development
849.66590.45505.75335.38299.73226.62198.44162.3135.2585.18
Upgrade
Other Operating Expenses
627.281,177525.77646.97464.79244.39237.07125.74129.69368.58
Upgrade
Operating Expenses
2,8203,1842,4831,8371,5011,155979.66790.93714.06859.87
Upgrade
Operating Income
578.58-65.53170.28378.07532.37614.84528.84591.65508.22195.59
Upgrade
Interest Expense / Income
289.44288.24278.7799.7172.2678.577.7661.9456.9252.71
Upgrade
Other Expense / Income
-5.7828.945.066.239.99.0810.98-2.3615.37-9.74
Upgrade
Pretax Income
294.92-382.71-113.55272.13450.21527.26440.11532.07435.93152.62
Upgrade
Income Tax
-119.91-158.65216.1233.52-73.1580.16-47.74135.24106.494.23
Upgrade
Net Income
414.83-224.06-329.67238.62523.37447.1487.85396.83329.5458.39
Upgrade
Net Income Growth
----54.41%17.06%-8.35%22.94%20.42%464.40%-73.01%
Upgrade
Shares Outstanding (Basic)
63636056576060616160
Upgrade
Shares Outstanding (Diluted)
72636057586161626363
Upgrade
Shares Change
15.23%4.77%5.62%-1.79%-6.00%-0.16%-0.89%-1.85%0.67%1.70%
Upgrade
EPS (Basic)
6.55-3.58-5.524.289.227.458.136.565.380.98
Upgrade
EPS (Diluted)
6.10-3.58-5.524.229.097.307.966.415.230.93
Upgrade
EPS Growth
----53.58%24.52%-8.29%24.18%22.56%462.37%-73.50%
Upgrade
Free Cash Flow
1,0681,243750.87884.64750.48826.43664.14582.7495.99371.26
Upgrade
Free Cash Flow Per Share
16.8819.8712.5815.8813.2213.7811.079.638.106.21
Upgrade
Gross Margin
88.64%85.23%85.76%93.70%94.08%93.57%93.19%92.92%92.26%89.99%
Upgrade
Operating Margin
15.09%-1.79%5.50%16.00%24.63%32.52%32.67%39.76%38.36%16.68%
Upgrade
Profit Margin
10.82%-6.12%-10.65%10.10%24.21%23.64%30.14%26.67%24.87%4.98%
Upgrade
Free Cash Flow Margin
27.86%33.97%24.27%37.43%34.72%43.71%41.03%39.16%37.44%31.65%
Upgrade
Effective Tax Rate
-40.66%--12.32%-16.25%15.20%-10.85%25.42%24.41%61.74%
Upgrade
EBITDA
1,223535.01717.7650.09892.63822.49683.02707.79600.91339.01
Upgrade
EBITDA Margin
31.90%14.62%23.19%27.50%41.29%43.50%42.20%47.57%45.36%28.90%
Upgrade
Depreciation & Amortization
638.7629.47552.48278.25370.16216.73165.15113.78108.06133.68
Upgrade
EBIT
584.36-94.46165.21371.84522.47605.76517.86594.01492.85205.33
Upgrade
EBIT Margin
15.24%-2.58%5.34%15.73%24.17%32.04%31.99%39.92%37.20%17.51%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).